OPKO Health (OPK) Beats Q4 Earnings and Revenue Estimates

Group 1 - OPKO Health reported quarterly earnings of $0.01 per share, exceeding the Zacks Consensus Estimate of a loss of $0.11 per share, compared to a loss of $0.09 per share a year ago [1] - The earnings surprise for this quarter was 109.09%, following a previous surprise of 130% when the company reported earnings of $0.03 per share against an expected loss of $0.10 per share [2] - The company generated revenues of $183.6 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 18.35%, and showing a slight increase from $181.9 million in the same quarter last year [3] Group 2 - OPKO Health shares have increased approximately 12.9% since the beginning of the year, outperforming the S&P 500's gain of 1.3% [4] - The company's earnings outlook is mixed, with the current consensus EPS estimate for the upcoming quarter at -$0.08 on revenues of $157.35 million, and -$0.26 on revenues of $675.16 million for the current fiscal year [8] - The Medical - Instruments industry, to which OPKO Health belongs, is currently ranked in the top 33% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [9]